GL1X · GenesisL1 explorer

MolNFT v1 · #87165 · protein

4BSN: Crystal structure of the nuclear export receptor CRM1 (exportin-1) lacking the C-terminal helical extension at 4.1A

4BSN: “Crystal structure of the nuclear export receptor CRM1 (exportin-1) lacking the C-terminal helical extension…”. X-ray diffraction, 5 pockets (best druggability 0.69). MolNFT v1 #87165 on GenesisL1: 3D structure, binding sites and…

3D structure of 4BSN: Crystal structure of the nuclear export receptor CRM1 (exportin-1) lacking the C-terminal helical extension at 4.1A (MolNFT v1 / PDB)
3D structure of 4BSN: Crystal structure of the nuclear export receptor CRM1 (exportin-1) lacking the C-terminal helical extension at 4.1A (MolNFT v1 / PDB)
PDB
4BSN
Type
protein
Length
707 residues
Chains
1
Method
x-ray diffraction
Deposited
11-JUN-13
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Exportin-1
UniProt
O14980
Pockets
5 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 73% helix, 1% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AExportin-1protein70773% helix, 1% strandO14980

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12150.690.8532empty
22710.650.8230empty
31480.480.7718empty
42370.480.7432empty
5790.480.8219empty

Compared structures

  • 4BSN · Crystal structure of the Nuclear Export Receptor CRM1 (exportin-1) lacking the C-terminal… · the same entry in another collection · chain A against A, TM-score 1.00
  • O14980 · AlphaFold monomer V2.0 prediction for exportin-1 (O14980) · a predicted model of the same protein · chain A against A, TM-score 0.87

Analyse

Other records of 4BSN

  • 4BSN · MolNFT v2 / PDB Bank · Crystal structure of the Nuclear Export Receptor CRM1 (exportin-1) lacking the C-terminal…

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.